# Biotech Daily Digest ‚Äî 2026-01-13

**44 items from 3 sources**

## Summary by Source

- Endpoints News: 12 items
- Fierce Biotech: 7 items
- arXiv q-bio: 25 items


## Endpoints News

- **[Marea takes drug for acromegaly to Phase 2](https://endpoints.news/marea-takes-drug-for-acromegaly-to-phase-2/)**  
  _Tue, 13 Jan 2026 13:00:12 +0000_  
  On Josh Lehrer's first day as CEO of Marea Therapeutics in October 2023, he found out the biotech's second pipeline drug hadn't lived up to the startup's expectations in a monkey study.

 The Bay Area ...

- **[Novartis licenses radiopharma asset from Chinese biotech for $50M upfront](https://endpoints.news/novartis-licenses-radiopharma-asset-from-chinese-biotech-for-50m-upfront/)**  
  _Tue, 13 Jan 2026 12:07:22 +0000_  
  Novartis is paying $50 million upfront to license a peptide-based radiopharmaceutical asset from China-headquartered Zonsen PepLib Biotech.

 The Monday release did not name the candidate, its target or what stage of ...

- **[#JPM26: Day 2 at the JP Morgan Healthcare Conference](https://endpoints.news/jpm26-day-2-at-the-jp-morgan-healthcare-conference/)**  
  _Tue, 13 Jan 2026 12:00:15 +0000_  
  We‚Äôre back for day 2 of the JP Morgan Healthcare Conference.

 On Monday, Amgen announced that its long-acting obesity shot MariTide succeeded in helping patients maintain weight loss in the second part of a Phase ...

- **[Congress' biotech panel pitches FDA policy upgrades to help performance](https://endpoints.news/embargo-congress-biotech-panel-pitches-fda-policy-upgrades-to-help-performance/)**  
  _Tue, 13 Jan 2026 05:01:10 +0000_  
  As the speed of biotech innovation outpaces regulators, a new report from the National Security Commission on Emerging Biotechnology is recommending almost two dozen policy changes to help the FDA navigate the space.

 The bipartisan ...

- **[Pretzel buys Rome and its ‚Äòdark genome‚Äô work](https://endpoints.news/pretzel-buys-rome-and-its-dark-genome-work/)**  
  _Mon, 12 Jan 2026 21:37:31 +0000_  
  Pretzel Therapeutics has acquired Rome Therapeutics and its "dark genome" work, Rome CEO Rosana Kapeller said in a LinkedIn post on Monday.

 The move followed months of

- **[Nvidia-partnered startup reveals AI-generated enzymes for precise gene insertion](https://endpoints.news/nvidia-partnered-startup-reveals-ai-generated-enzymes-for-precise-gene-insertion/)**  
  _Mon, 12 Jan 2026 21:18:10 +0000_  
  Scientists at Basecamp Research say they have used ‚Äúevolutionary AI models,‚Äù developed with help from chipmaker Nvidia, to create a powerful new gene editing tool that can insert a new healthy gene in front of ...

- **[At FDA's request, Pfizer helps ease shortage of potential autism drug](https://endpoints.news/at-fdas-request-pfizer-helps-ease-shortage-of-potential-autism-drug/)**  
  _Mon, 12 Jan 2026 19:49:26 +0000_  
  HHS confirmed that it enlisted Pfizer to help combat the shortage of a drug that Robert F. Kennedy Jr.'s department is promoting as a potential new autism drug despite shaky evidence.

 Pfizer told healthcare providers ...

- **[FDA lifts partial hold on Merck, Daiichi's Phase 3 lung cancer study](https://endpoints.news/fda-lifts-partial-hold-on-merck-daiichis-phase-3-lung-cancer-study/)**  
  _Mon, 12 Jan 2026 17:47:28 +0000_  
  The FDA on Monday lifted a partial clinical hold on a Phase 3 lung cancer study run by Merck and Daiichi Sankyo.

 Regulators had placed the hold just last month after seeing ...

- **[Eisai licenses Nuvation lung cancer pill; Alnylam's stock dips after sales data report](https://endpoints.news/eisai-licenses-nuvation-lung-cancer-pill-alnylams-stock-dips-after-sales-data-report/)**  
  _Mon, 12 Jan 2026 16:22:25 +0000_  
  Plus, news about Summit, Pfizer, Insmed, Bristol Myers Squibb, Lynk Pharmaceuticals, Stoke Therapeutics, UniQure, Teva, Royalty Pharma, Vibrant Therapeutics and Recludix Pharma:

 üíä Nuvation Bio licenses lung cancer pill to Eisai: The Japanese company has ...

- **[AbbVie jumps into PD-1xVEGF bispecific race, pays $650M upfront to RemeGen](https://endpoints.news/abbvie-jumps-into-bispecific-race-pays-650m-upfront-to-remegen/)**  
  _Mon, 12 Jan 2026 15:41:14 +0000_  
  AbbVie is kicking off the JP Morgan Healthcare Conference with a deal in one of oncology‚Äôs hottest fields.

 AbbVie announced Monday it will pay $650 million upfront to Chinese biotech RemeGen to partner on a ...

- **[Eli Lilly, Nvidia sign five-year, up to $1B deal for AI laboratory](https://endpoints.news/eli-lilly-nvidia-sign-five-year-up-to-1b-deal-for-ai-laboratory/)**  
  _Mon, 12 Jan 2026 15:00:19 +0000_  
  Two of the world's largest companies are deepening their ties, after already signing a pact to build pharma's largest supercomputer.

 On Monday, drugmaker Eli Lilly and AI chip giant Nvidia announced a ...

- **[#JPM26: Day 1 at the JP Morgan Healthcare Conference](https://endpoints.news/jpm26-day-1-at-the-jp-morgan-healthcare-conference/)**  
  _Mon, 12 Jan 2026 12:00:14 +0000_  
  As the first day of the JP Morgan Healthcare Conference progressed, we heard a lot of talk about deals ‚Äî they‚Äôre a "top priority" for Bristol Myers CEO Chris Boerner, and Moderna is looking at "a ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/medtech/medtronic-step-ma-medtech-has-capacity-deals" hreflang="en">JPM26: Medtronic to 'step up' in M&amp;A as medtech has 'capacity' for deals, exec says</a>](https://www.fiercebiotech.com/medtech/medtronic-step-ma-medtech-has-capacity-deals)**  
  _Jan 13, 2026 5:42am_  
  While the 2026 J.P. Morgan Healthcare Conference has thus far failed to yield any major M&A deals for the industry, Medtronic believes the time is ripe for buyouts.

- **[<a href="https://www.fiercebiotech.com/biotech/jpm26-takedas-rd-head-talks-slow-monday-biggest-threat-us-innovation-phoenix-rising-ashes" hreflang="en">JPM26: Takeda's R&amp;D head talks slow Monday, the biggest threat to US innovation and a phoenix rebirth</a>](https://www.fiercebiotech.com/biotech/jpm26-takedas-rd-head-talks-slow-monday-biggest-threat-us-innovation-phoenix-rising-ashes)**  
  _Jan 13, 2026 1:16am_  
  It‚Äôs been a subdued‚Äîalbeit sunny‚Äîstart to healthcare‚Äôs biggest conference in San Francisco. For Takeda's R&D head¬†Andy Plump, M.D., Ph.D., the slower pace of the annual J.P. Morgan Healthcare Conference has been offset by the industry's consistent dealmaking over the last several months.

- **[<a href="https://www.fiercebiotech.com/biotech/fierce-biotechs-jpm26-tracker-day-1" hreflang="en">JPM26, Day 1: Lilly, Nvidia expand AI team-up; Takeda R&amp;D head talks lack of deal announcements</a>](https://www.fiercebiotech.com/biotech/fierce-biotechs-jpm26-tracker-day-1)**  
  _Jan 8, 2026 3:33pm_  
  The life sciences world is once again converging in San Francisco as the J.P. Morgan Healthcare Conference kicks off for 2026. Fierce Biotech is here tracking the biggest deals, data drops and industry shifts as they happen.

- **[<a href="https://www.fiercebiotech.com/pharma/bristol-myers-ceo-cast-broad-net-business-development-remains-top-priority" hreflang="en">JPM26: Bristol Myers CEO to 'cast a broad net' as business development remains a top priority</a>](https://www.fiercebiotech.com/pharma/bristol-myers-ceo-cast-broad-net-business-development-remains-top-priority)**  
  _Jan 12, 2026 3:06pm_  
  SAN FRANCISCO‚ÄîBristol Myers Squibb is already aiming to launch more than 10 new medicines by 2030. But to hear CEO Chris Boerner, Ph.D., tell it, ‚Äúbusiness development remains a top priority‚Äù for the company‚Äôs capital allocation strategy heading into 2026.

- **[<a href="https://www.fiercebiotech.com/biotech/abbvie-pens-56b-pact-remegen-join-pd1xvegf-bispecific-battle" hreflang="en">AbbVie pens $5.6B pact with RemeGen to join PD-1xVEGF bispecific battle</a>](https://www.fiercebiotech.com/biotech/abbvie-pens-56b-pact-remegen-join-pd1xvegf-bispecific-battle)**  
  _Jan 12, 2026 10:20am_  
  AbbVie has made no secret of the fact that it's taken an interest in the hotly contested PD-1xVEGF bispecific space. Now, the Big Pharma has paid $650 million to make its ambitions in this arena a reality.

- **[<a href="https://www.fiercebiotech.com/biotech/lilly-nvidia-tag-partnership-new-ai-co-innovation-lab-1b-investment" hreflang="en">Lilly, Nvidia tag on partnership with new AI co-innovation lab, $1B investment </a>](https://www.fiercebiotech.com/biotech/lilly-nvidia-tag-partnership-new-ai-co-innovation-lab-1b-investment)**  
  _Jan 9, 2026 4:11pm_  
  Eli Lilly and Nvidia, two primary drivers of the recent stock market rally, are deepening their alliance to connect silicon with biology through AI-powered drug development.

- **[<a href="https://www.fiercebiotech.com/medtech/bayer-boosts-imaging-portfolio-attralus-deal-2-diagnostic-tracers" hreflang="en">Bayer boosts imaging portfolio with Attralus deal for 2 diagnostic tracers</a>](https://www.fiercebiotech.com/medtech/bayer-boosts-imaging-portfolio-attralus-deal-2-diagnostic-tracers)**  
  _Jan 12, 2026 9:13am_  
  Bayer, looking to bolster its position in both imaging and cardiac medicine, struck a deal to snap up two experimental imaging agents and thereby enter the diagnostic tracers development space.


## arXiv q-bio

- **[Gamma2Patterns: Deep Cognitive Attention Region Identification and Gamma-Alpha Pattern Analysis](https://arxiv.org/abs/2601.06257)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2601.06257v1 Announce Type: new 
Abstract: Deep cognitive attention is characterized by heightened gamma oscillations and coordinated visual behavior. Despite the physiological importance of these mechanisms, computational studies rarely synthesize these modalities or identify the neural regions most responsible‚Ä¶

- **[Designing a Resilient Allee-Ornstein-Uhlenbeck model](https://arxiv.org/abs/2601.06354)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2601.06354v1 Announce Type: new 
Abstract: In stochastic population dynamics, stochastic wandering can produce transition to an absorbing state. In particular, under Allee effects, low densities amplify the possibility of population collapse. We investigate this in an Allee-Ornstein-Uhlenbeck (Allee-OU) model, t‚Ä¶

- **[Computational Mapping of Reactive Stroma in Prostate Cancer Yields Interpretable, Prognostic Biomarkers](https://arxiv.org/abs/2601.06360)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2601.06360v1 Announce Type: new 
Abstract: Current histopathological grading of prostate cancer relies primarily on glandular architecture, largely overlooking the tumor microenvironment. Here, we present PROTAS, a deep learning framework that quantifies reactive stroma (RS) in routine hematoxylin and eosin (H&E‚Ä¶

- **[Neuronal Spike Trains as Functional-Analytic Distributions: Representation, Analysis, and Significance](https://arxiv.org/abs/2601.07215)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2601.07215v1 Announce Type: new 
Abstract: The action potential constitutes the digital component of the signaling dynamics of neurons. But the biophysical nature of the full time course of the action potential associated with changes in membrane potential is fundamentally and mathematically distinct from its re‚Ä¶

- **[Charting the velocity of brain growth and development](https://arxiv.org/abs/2601.07591)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2601.07591v1 Announce Type: new 
Abstract: Brain charts have emerged as a highly useful approach for understanding brain development and aging on the basis of brain imaging and have shown substantial utility in describing typical and atypical brain development with respect to a given reference model. However, al‚Ä¶

- **[A Framework for Feature Discovery in Intracranial Pressure Monitoring Data Using Neural Network Attention](https://arxiv.org/abs/2601.07691)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2601.07691v1 Announce Type: new 
Abstract: We present a novel framework for analyzing intracranial pressure monitoring data by applying interpretability principles. Intracranial pressure monitoring data was collected from 60 patients at Johns Hopkins. The data was segmented into individual cardiac cycles. A conv‚Ä¶

- **[Using Non-Linear Programming Solvers to Generate Hypothalamus-Pituitary Curves for Patients With Hypothyroidism](https://arxiv.org/abs/2601.07819)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2601.07819v1 Announce Type: new 
Abstract: Common practice in treating primary hypothyroidism is to use only Thyrothropin (TSH) to adjust the dose of thyroid replacement. In this paper, it is argued that using both TSH and free Thyroxine (FT4) values in the replacement may be beneficial in the treatment of hypot‚Ä¶

- **[Histopathology-centered Computational Evolution of Spatial Omics: Integration, Mapping, and Foundation Models](https://arxiv.org/abs/2601.07826)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2601.07826v1 Announce Type: new 
Abstract: Spatial omics (SO) technologies enable spatially resolved molecular profiling, while hematoxylin and eosin (H&E) imaging remains the gold standard for morphological assessment in clinical pathology. Recent computational advances increasingly place H&E images at the cent‚Ä¶

- **[Auditory Filter Behavior and Updated Estimated Constants](https://arxiv.org/abs/2601.06094)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2601.06094v1 Announce Type: cross 
Abstract: Filters from the Gammatone family are often used to model auditory signal processing, but the filter constant values used to mimic human hearing are largely set to values based on historical psychoacoustic data collected several decades ago. Here, we move away from th‚Ä¶

- **[DeeperBrain: A Neuro-Grounded EEG Foundation Model Towards Universal BCI](https://arxiv.org/abs/2601.06134)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2601.06134v1 Announce Type: cross 
Abstract: Electroencephalography (EEG) foundation models hold significant promise for universal Brain-Computer Interfaces (BCIs). However, existing approaches often rely on end-to-end fine-tuning and exhibit limited efficacy under frozen-probing protocols, lacking the intrinsic‚Ä¶

- **[Dynamics-inspired Structure Hallucination for Protein-protein Interaction Modeling](https://arxiv.org/abs/2601.06214)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2601.06214v1 Announce Type: cross 
Abstract: Protein-protein interaction (PPI) represents a central challenge within the biology field, and accurately predicting the consequences of mutations in this context is crucial for drug design and protein engineering. Deep learning (DL) has shown promise in forecasting t‚Ä¶

- **[Hierarchical Pooling and Explainability in Graph Neural Networks for Tumor and Tissue-of-Origin Classification Using RNA-seq Data](https://arxiv.org/abs/2601.06381)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2601.06381v1 Announce Type: cross 
Abstract: This study explores the use of graph neural networks (GNNs) with hierarchical pooling and multiple convolution layers for cancer classification based on RNA-seq data. We combine gene expression data from The Cancer Genome Atlas (TCGA) with a precomputed STRING protein‚Ä¶

- **[In-context learning emerges in chemical reaction networks without attention](https://arxiv.org/abs/2601.06712)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2601.06712v1 Announce Type: cross 
Abstract: We investigate whether chemical processes can perform in-context learning (ICL), a mode of computation typically associated with transformer architectures. ICL allows a system to infer task-specific rules from a sequence of examples without relying solely on fixed par‚Ä¶

- **[Continuous Energy Landscape Model for Analyzing Brain State Transitions](https://arxiv.org/abs/2601.06991)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2601.06991v1 Announce Type: cross 
Abstract: Energy landscape models characterize neural dynamics by assigning energy values to each brain state that reflect their stability or probability of occurrence. The conventional energy landscape models rely on binary brain state representation, where each region is cons‚Ä¶

- **[Largest connected component in duplication-divergence growing graphs with symmetric coupled divergence](https://arxiv.org/abs/2601.07024)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2601.07024v1 Announce Type: cross 
Abstract: The largest connected component in duplication-divergence growing graphs with symmetric coupled divergence is studied. Finite-size scaling reveals a phase transition occurring at a divergence rate $\delta_c$. The $\delta_c$ found stands near the locus of zero in Euler‚Ä¶

- **[Modeling and analysis of a novel two-strain dengue epidemics model considering secondary infections with increased mortality](https://arxiv.org/abs/2601.07403)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2601.07403v1 Announce Type: cross 
Abstract: In this study, we develop and analyze a deterministic two-strain host--vector model for dengue transmission that incorporates key immuno-epidemiological mechanisms, including temporary cross-immunity, antibody-dependent enhancement (ADE), disease-induced mortality dur‚Ä¶

- **[PLANET v2.0: A comprehensive Protein-Ligand Affinity Prediction Model Based on Mixture Density Network](https://arxiv.org/abs/2601.07415)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2601.07415v1 Announce Type: cross 
Abstract: Drug discovery represents a time-consuming and financially intensive process, and virtual screening can accelerate it. Scoring functions, as one of the tools guiding virtual screening, have their precision closely tied to screening efficiency. In our previous study, w‚Ä¶

- **[Optimal Learning Rate Schedule for Balancing Effort and Performance](https://arxiv.org/abs/2601.07830)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2601.07830v1 Announce Type: cross 
Abstract: Learning how to learn efficiently is a fundamental challenge for biological agents and a growing concern for artificial ones. To learn effectively, an agent must regulate its learning speed, balancing the benefits of rapid improvement against the costs of effort, inst‚Ä¶

- **[Backpropagation through space, time, and the brain](https://arxiv.org/abs/2403.16933)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2403.16933v4 Announce Type: replace 
Abstract: How physical networks of neurons, bound by spatio-temporal locality constraints, can perform efficient credit assignment, remains, to a large extent, an open question. In machine learning, the answer is almost universally given by the error backpropagation algorithm‚Ä¶

- **[Topological model selection: a case-study in tumour-induced angiogenesis](https://arxiv.org/abs/2504.15442)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2504.15442v2 Announce Type: replace 
Abstract: Comparing mathematical models offers a means to evaluate competing scientific theories. However, exact methods of model calibration are not applicable to many probabilistic models which simulate high-dimensional spatio-temporal data. Approximate Bayesian Computation‚Ä¶

- **[Notation-level confounding: When inconsistent molecular notations mislead chemical language models](https://arxiv.org/abs/2505.07139)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2505.07139v4 Announce Type: replace 
Abstract: Chemical language models (CLMs) are increasingly used for molecular design and property prediction. Because these models learn from textual encodings of molecules, differences in how such encodings are generated may affect their behavior. In cheminformatics, the ter‚Ä¶

- **[Synthetic Data Generation for Classifying Electrophysiological and Morpho-Electrophysiological Neurons from Mouse Visual Cortex](https://arxiv.org/abs/2508.06514)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2508.06514v2 Announce Type: replace 
Abstract: The accurate classification of neuronal cell types is central to decoding brain function, yet remains hindered by data scarcity and cellular heterogeneity. Here, we benchmarked classical and deep generative synthetic data augmentation strategies -- including SMOTE,‚Ä¶

- **[When is local search both effective and efficient?](https://arxiv.org/abs/2410.02634)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2410.02634v3 Announce Type: replace-cross 
Abstract: Combinatorial optimization problems implicitly define fitness landscapes that combine the numeric structure of the 'fitness' function to be maximized with the combinatorial structure of which assignments are 'adjacent'. Local search starts at an assignment in‚Ä¶

- **[EEG-to-fMRI synthesis of task-evoked and spontaneous brain activity: addressing issues of statistical significance and generalizability](https://arxiv.org/abs/2504.10752)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2504.10752v2 Announce Type: replace-cross 
Abstract: A growing interest has developed in the problem of training models of EEG features to predict brain activity measured using fMRI, i.e. the problem of EEG-to-fMRI synthesis. Despite some reported success, the statistical significance and generalizability of EEG‚Ä¶

- **[HuiduRep: A Robust Self-Supervised Framework for Learning Neural Representations from Extracellular Recordings](https://arxiv.org/abs/2507.17224)**  
  _Tue, 13 Jan 2026 00:00:00 -0500_  
  arXiv:2507.17224v3 Announce Type: replace-cross 
Abstract: Extracellular recordings are transient voltage fluctuations in the vicinity of neurons, serving as a fundamental modality in neuroscience for decoding brain activity at single-neuron resolution. Spike sorting, the process of attributing each detected spike to‚Ä¶
